Hideho Okada

47PUBLICATIONS
228CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Nov 06, 2026
Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma.

|Oct 28, 2026
Brain-sensing synNotch-CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical models.

|Jul 29, 2026
ITPKB is a conserved regulator of natural killer cell desensitization/education that constrains antitumor immunity.

|Jun 29, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

|Jun 26, 2026
In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma.

|May 29, 2026
Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.

Pageof 8

Frequent Collaborators

10 joint publications

Takahide Nejo

5 joint publications

Senthilnath Lakshmanachetty

4 joint publications

Masaki Terabe

4 joint publications

Pavlina Chuntova